288 related articles for article (PubMed ID: 8903406)
21. Characterization of the UDP-glucuronosyltransferases involved in the glucuronidation of an antithrombotic thioxyloside in rat and humans.
Pless D; Gouze JN; Senay C; Herber R; Leroy P; Barberousse V; Fournel-Gigleux S; Magdalou J
Drug Metab Dispos; 1999 May; 27(5):588-95. PubMed ID: 10220487
[TBL] [Abstract][Full Text] [Related]
22. Effects of model traumatic injury on hepatic drug metabolism in the rat. IV. Glucuronidation.
Griffeth LK; Rosen GM; Rauckman EJ
Drug Metab Dispos; 1985; 13(4):391-7. PubMed ID: 2863100
[TBL] [Abstract][Full Text] [Related]
23. Microsomal azoreduction and glucuronidation in the metabolism of dimethylaminoazobenzene by the rat liver.
Raza H; Levine WG; Chowdhury NR; Chowdhury JR
Xenobiotica; 1987 Jun; 17(6):669-77. PubMed ID: 3114967
[TBL] [Abstract][Full Text] [Related]
24. Glucuronidation of thyroid hormone in rat liver: effects of in vivo treatment with microsomal enzyme inducers and in vitro assay conditions.
Visser TJ; Kaptein E; van Toor H; van Raaij JA; van den Berg KJ; Joe CT; van Engelen JG; Brouwer A
Endocrinology; 1993 Nov; 133(5):2177-86. PubMed ID: 8404669
[TBL] [Abstract][Full Text] [Related]
25. Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism.
Picard N; Ratanasavanh D; Prémaud A; Le Meur Y; Marquet P
Drug Metab Dispos; 2005 Jan; 33(1):139-46. PubMed ID: 15470161
[TBL] [Abstract][Full Text] [Related]
26. Effect of Glycyrrhiza glabra roots and glycyrrhizin on the glucuronidation in rats.
Moon A; Kim SH
Planta Med; 1997 Apr; 63(2):115-9. PubMed ID: 9140223
[TBL] [Abstract][Full Text] [Related]
27. Induction of rat UDP-glucuronosyltransferases in liver and duodenum by microsomal enzyme inducers that activate various transcriptional pathways.
Shelby MK; Klaassen CD
Drug Metab Dispos; 2006 Oct; 34(10):1772-8. PubMed ID: 16855052
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of covalent adduct formation of diclofenac to rat hepatic microsomal proteins. Retention of the glucuronic acid moiety in the adduct.
Kretz-Rommel A; Boelsterli UA
Drug Metab Dispos; 1994; 22(6):956-61. PubMed ID: 7895615
[TBL] [Abstract][Full Text] [Related]
29. Characterization of benzazepine UDP-glucuronosyl-transferases in laboratory animals and man.
Hansen KT; Stentoft K
Xenobiotica; 1995 Jun; 25(6):611-22. PubMed ID: 7483661
[TBL] [Abstract][Full Text] [Related]
30. Male rat hepatic UDP-glucuronosyltransferase activity toward thyroxine. Activation and induction properties--relation with thyroxine plasma disappearance rate.
de Sandro V; Catinot R; Kriszt W; Cordier A; Richert L
Biochem Pharmacol; 1992 Apr; 43(7):1563-9. PubMed ID: 1567478
[TBL] [Abstract][Full Text] [Related]
31. Effects of cyclophosphamide and adriamycin on rat hepatic microsomal glucuronidation and lipid peroxidation.
Lear L; Nation RL; Stupans I
Biochem Pharmacol; 1992 Aug; 44(4):747-53. PubMed ID: 1510722
[TBL] [Abstract][Full Text] [Related]
32. Copper modifies liver microsomal UDP-glucuronyltransferase activity through different and opposite mechanisms.
Letelier ME; Lagos F; Faúndez M; Miranda D; Montoya M; Aracena-Parks P; González-Lira V
Chem Biol Interact; 2007 Apr; 167(1):1-11. PubMed ID: 17274970
[TBL] [Abstract][Full Text] [Related]
33. Carboxyl-glucuronidation of mitiglinide by human UDP-glucuronosyltransferases.
Yu L; Lu S; Lin Y; Zeng S
Biochem Pharmacol; 2007 Jun; 73(11):1842-51. PubMed ID: 17359941
[TBL] [Abstract][Full Text] [Related]
34. Effect of selective phase II enzyme inducers on glucuronidation of benoxaprofen in rats.
Dong JQ; Etheridge AS; Smith PC
Drug Metab Dispos; 1999 Dec; 27(12):1423-8. PubMed ID: 10570023
[TBL] [Abstract][Full Text] [Related]
35. Effects of silymarin on UDP-glucuronic acid and glucuronidation activity in the rat isolated hepatocytes and liver in relation to D-galactosamine toxicity.
Chrungoo VJ; Reen RK; Singh K; Singh J
Indian J Exp Biol; 1997 Mar; 35(3):256-63. PubMed ID: 9332170
[TBL] [Abstract][Full Text] [Related]
36. Glucuronidation of retinoids by rat recombinant UDP: glucuronosyltransferase 1.1 (bilirubin UGT).
Radominska A; Little JM; Lehman PA; Samokyszyn V; Rios GR; King CD; Green MD; Tephly TR
Drug Metab Dispos; 1997 Jul; 25(7):889-92. PubMed ID: 9224784
[TBL] [Abstract][Full Text] [Related]
37. Similarities and differences in the glucuronidation of estradiol and estrone by UDP-glucuronosyltransferase in liver microsomes from male and female rats.
Zhu BT; Suchar LA; Huang MT; Conney AH
Biochem Pharmacol; 1996 May; 51(9):1195-202. PubMed ID: 8645343
[TBL] [Abstract][Full Text] [Related]
38. Characterization of rat intestinal microsomal UDP-glucuronosyltransferase activity toward mycophenolic acid.
Miles KK; Kessler FK; Smith PC; Ritter JK
Drug Metab Dispos; 2006 Sep; 34(9):1632-9. PubMed ID: 16790558
[TBL] [Abstract][Full Text] [Related]
39. Effect of inducers and inhibitors of glucuronidation on the biliary excretion and choleretic action of valproic acid in the rat.
Watkins JB; Klaassen CD
J Pharmacol Exp Ther; 1982 Feb; 220(2):305-10. PubMed ID: 6799642
[TBL] [Abstract][Full Text] [Related]
40. The glucuronidation of Delta4-3-Keto C19- and C21-hydroxysteroids by human liver microsomal and recombinant UDP-glucuronosyltransferases (UGTs): 6alpha- and 21-hydroxyprogesterone are selective substrates for UGT2B7.
Bowalgaha K; Elliot DJ; Mackenzie PI; Knights KM; Miners JO
Drug Metab Dispos; 2007 Mar; 35(3):363-70. PubMed ID: 17151189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
